Hydroxyurea structure
|
Common Name | Hydroxyurea | ||
---|---|---|---|---|
CAS Number | 127-07-1 | Molecular Weight | 76.055 | |
Density | 1.5±0.1 g/cm3 | Boiling Point | 222.1±23.0 °C at 760 mmHg | |
Molecular Formula | CH4N2O2 | Melting Point | 135-140 °C | |
MSDS | Chinese | Flash Point | 88.1±22.6 °C | |
Symbol |
GHS08 |
Signal Word | Danger |
Use of HydroxyureaHydroxyurea is a cell apoptosis inducer that inhibitDNA synthesis through inhibition of ribonucleotide reductase. |
Name | hydroxyurea |
---|---|
Synonym | More Synonyms |
Description | Hydroxyurea is a cell apoptosis inducer that inhibitDNA synthesis through inhibition of ribonucleotide reductase. |
---|---|
Related Catalog | |
In Vitro | Hydroxyurea is used in a number of myeloproliferative, neoplastic, HIV, and non-hematological diseases[1]. Treatment of cells in primary culture with 30 μM hydroxyurea for 96 hours significantly increases the fractional HbF content. The Gγ: Aγ-globin mRNA is induced 0.30- to 8-fold in vitro[2]. Hydroxyurea has been shown to block HIV-1 reverse transcription and/or replication in quiescent peripheral blood mononuclear cells and macrophages[3]. |
In Vivo | Hydroxyurea therapy producs consistent reductions in WBC and ANC without improvement in anemia over 17 weeks. Hydroxyurea at 50mg/kg produces a reduced white blood cell count, absolute neutrophil count and no improvement in anemia compared to vehicle treated sickle cell mice[4]. |
Animal Admin | Mice: To determine whether hydroxyurea would improve anemia and/or prevent or diminish the development of organ damage in the absence of HbF induction, hydroxyurea, at doses of 25 mg/kg, 50 mg/kg, and 100 mg/kg, or vehicle is administered five days per week to SCD mice[4]. |
References |
Density | 1.5±0.1 g/cm3 |
---|---|
Boiling Point | 222.1±23.0 °C at 760 mmHg |
Melting Point | 135-140 °C |
Molecular Formula | CH4N2O2 |
Molecular Weight | 76.055 |
Flash Point | 88.1±22.6 °C |
Exact Mass | 76.027275 |
PSA | 75.35000 |
LogP | -1.80 |
Vapour Pressure | 0.0±1.0 mmHg at 25°C |
Index of Refraction | 1.501 |
Storage condition | 2-8°C |
Water Solubility | soluble |
Symbol |
GHS08 |
---|---|
Signal Word | Danger |
Hazard Statements | H340-H361 |
Precautionary Statements | P201-P280-P308 + P313 |
Personal Protective Equipment | Eyeshields;full-face particle respirator type N100 (US);Gloves;respirator cartridge type N100 (US);type P1 (EN143) respirator filter;type P3 (EN 143) respirator cartridges |
Hazard Codes | T:Toxic |
Risk Phrases | R46;R61 |
Safety Phrases | S53-S36/37-S45 |
RIDADR | 2811 |
WGK Germany | 3 |
RTECS | YT4900000 |
Packaging Group | III |
HS Code | 2928000090 |
Precursor 9 | |
---|---|
DownStream 10 | |
HS Code | 2924199090 |
---|---|
Summary | 2924199090. other acyclic amides (including acyclic carbamates) and their derivatives; salts thereof. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:30.0% |
Rad23 interaction with the proteasome is regulated by phosphorylation of its ubiquitin-like (UbL) domain.
J. Mol. Biol. 426(24) , 4049-60, (2014) Rad23 was identified as a DNA repair protein, although a role in protein degradation has been described. The protein degradation function of Rad23 contributes to cell cycle progression, stress respons... |
|
A gemcitabine sensitivity screen identifies a role for NEK9 in the replication stress response.
Nucleic Acids Res. 42(18) , 11517-27, (2014) The Replication Stress Response (RSR) is a signaling network that recognizes challenges to DNA replication and coordinates diverse DNA repair and cell-cycle checkpoint pathways. Gemcitabine is a nucle... |
|
Celastrol induces proteasomal degradation of FANCD2 to sensitize lung cancer cells to DNA crosslinking agents.
Cancer Sci. 106 , 902-8, (2015) The Fanconi anemia (FA) pathway plays a key role in interstrand crosslink (ICL) repair and maintenance of the genomic stability, while inhibition of this pathway may sensitize cancer cells to DNA ICL ... |
hydroxycarbamide |
HYDROXYUREA (HYDROXYCARBAMIDE) |
HYDROXYUREA 127-07-1 |
Hydroxyurea |
Droxia |
HYDROXYCARBAMIDE, BP STANDARD |
HYDROXYHARNSTOFF |
amino-hydroxamic acid |
Hydrea |
HYDROXYHARNSTOFF(HYDROXYUREA) |
1-hydroxyure |
hydroxyl urea |
Hydroxy urea |
HYDROXYCARBAMIDE (HYDROXYUREA) |
MFCD00007943 |
Urea, N-hydroxy- |
Onco-carbide |
Oxyurea |
N-HYDROXYUREA |
EINECS 204-821-7 |
Litalir |
1-Hydroxyurea |
Biosupressin |
hydroxyure |